ArticleJournal of fluorescence2026
Isoniazid-Derived Schiff Base Chemosensor for Dual-Mode Detection of Metal Ions and Bio-imaging Applications.
Article in Journal of fluorescence, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Fluorescent Chemosensors as Precision Tools for Bioimaging and Environmental Monitoring: Advances, Challenges, and Future Directions.Journal of fluorescence · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study discusses a Schiff base chemosensor ((E)-N’-(2-hydroxybenzylidene)isonicotinohydrazide (HISN)), specifically designed for the rapid detection of Cu²⁺ and Ni²⁺ ions in aqueous medium. HISN characterization was conducted using various methods, including FT-IR, HRMS, ¹H NMR, ¹³C NMR, fluorometric techniques, and UV-Visible spectroscopy. In an acetonitrile solution (1 µM, pH = 7.4), HISN exhibited a noticeable and significant color change from colorless to yellow when exposed to Cu²⁺ and Ni²⁺ ions. The UV-visible absorption spectrum of the HISN-Cu²⁺ and HISN-Ni²⁺ complexes displayed both bathochromic (red) and hypsochromic (blue) shifts. Additionally, the presence of Cu²⁺ and Ni²⁺ ions notably increased the fluorescence intensity of HISN. The limits of detection (LOD) and quantification (LOQ) for HISN with respect to Cu²⁺ and Ni²⁺ ions were established. The LOD values are 3.394 × 10− 9 M for Cu²⁺ and 1.646 × 10− 7 M for Ni²⁺, while the corresponding LOQ values are 1.131 × 10− 8 M for Cu²⁺ and 5.487 × 10− 7 M for Ni²⁺. Data analysis from Job’s plot, along with HRMS and FT-IR spectral data, suggested a 1:1 stoichiometric relationship between HISN and both Cu²⁺ and Ni²⁺ ions. Further, the complex formation between HISN-Cu2+ and HISN-Ni2+ was confirmed by Density Functional Theory (DFT) calculations using Gaussian 16 software. Geometry optimization of these complexes is carried out using the exchange-correlation functional B3PW91 and the basis set 6-311 + G(d, p). MTT assay results indicated that HISN formulations are cytocompatible and do not harm cells at varying concentrations. Furthermore, HISN has been utilized as a fluorescent imaging probe for intracellular Cu²⁺and Ni²⁺ ions.
Indexed as
Identifiers
42043762What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.